Role of liver biopsy in management of chronic hepatitis C: A systematic review
- 1 November 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 36, s161-s172
- https://doi.org/10.1053/jhep.2002.36989
Abstract
This systematic review addresses 2 questions pertinent to the need for pretreatment liver biopsy in patients with chronic hepatitis C: how well do liver biopsy results predict treatment outcomes for chronic hepatitis C? How well do biochemical blood tests and serologic measures of fibrosis predict the biopsy findings in chronic hepatitis C? Medline and other electronic databases were searched from January 1985 to March 2002. Additional articles were sought in references of pertinent articles and recent journals and by querying experts. Articles were eligible for review if they reported original human data from a study that used virological, histological, pathologic, or clinical outcome measures. Paired reviewers assessed the quality of each eligible study and abstracted data. Studies suggested that advanced fibrosis or cirrhosis on initial liver biopsy is associated with a modestly decreased likelihood of a sustained virological response (SVR) to treatment. Also, studies relatively consistently showed that serum aminotransferases have modest value in predicting fibrosis on biopsy; that extracellular matrix tests hyaluronic acid and laminin may have value in predicting fibrosis, and that panels of tests may have the greatest value in predicting fibrosis or cirrhosis. Biochemical and serologic tests were best at predicting no or minimal fibrosis, or at predicting advanced fibrosis/cirrhosis, and were poor at predicting intermediate levels of fibrosis. Thus, evidence suggests that liver biopsy may have some usefulness in predicting efficacy of treatment in patients with chronic hepatitis C, and biochemical blood tests and serologic tests currently have only modest value in predicting fibrosis on liver biopsy.Keywords
Funding Information
- Agency for Healthcare Research and Quality (290-97-0006)
- National Institutes of Health to Dr. Sulkowski (RO1-DA-13806)
This publication has 73 references indexed in Scilit:
- Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histologyJournal of Gastroenterology and Hepatology, 2000
- An assessment of the clinical utility of serum ALT and AST in chronic hepatitis CHepatology Research, 2000
- Correlation of viral RNA, alanine aminotransferase, and histopathology in hepatitis C virus-associated hepatitisMolecular Diagnosis, 1999
- Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon‐αAlimentary Pharmacology & Therapeutics, 1998
- Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon α-2b for chronic hepatitis type C: Results of a multicenter randomized trialJournal of Hepatology, 1997
- Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C: Relationship to interferon reponseJournal of Hepatology, 1997
- Correlation of soluble interleukin-2 receptor levels with severity of chronic hepatitis C virus liver injury and development of hepatocellular cancerSurgery, 1996
- Serum hyaluronic acid reflects the effect of interferon treatment on hepatic fibrosis in patients with chronic hepatitis CJournal of Gastroenterology and Hepatology, 1996
- Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virusDigestive Diseases and Sciences, 1996
- Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis CJournal of Hepatology, 1994